Skip to main content
Equibles

Caitong International Asset Management Co., Ltd

Position in EVO — Evotec SE

CIK 1963355 HONG KONG, K3
Back to EVO Full portfolio

Position in EVO

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$8
New position
Shares Held
3
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 34 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority Sole 0% Shared 0% None 100%

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Caitong International Asset Management Co., Ltd holds $770,442 across 41 Drug Manufacturers - Specialty & Generic names. EVO ranks #31 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BCRX
Biocryst Pharmaceuticals Inc
 20,925 $209,250
2 RDY
Dr Reddys Laboratories Ltd
 11,751 $170,271
3 TAK
Takeda Pharmaceutical Co Ltd
 6,656 $106,695
4 TEVA
Teva Pharmaceutical Industries Ltd
 2,099 $71,114
5 SUPN
Supernus Pharmaceuticals, Inc.
 973 $45,254
6 ETON
Eton Pharmaceuticals, Inc.
 842 $30,480
7 LQDA
Liquidia Corp
 331 $26,390
8 XERS
Xeris Biopharma Holdings, Inc.
 2,746 $21,748

All Filings in EVO

Export CSV
1 filing row on record
Report Date Value (USD) Shares
2026-06-30 $8 3